Frontiers in Nuclear Medicine

Original Research

Published on 11 Jan 2024

Comparative effectiveness of standard vs. AI-assisted PET/CT reading workflow for pre-treatment lymphoma staging: a multi-institutional reader study evaluation

Russell Frood
Julien M. Y. Willaime
Brad Miles
Greg Chambers
H’ssein Al-Chalabi
Tamir Ali
Natasha Hougham
Naomi Brooks
George Petrides
Matthew Naylor

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2023.1327186

4,786 views
5 citations

Editorial

Published on 11 Jan 2024

Editorial: Molecular imaging of cardiovascular diseases: current and emerging approaches in nuclear medicine

Jonathan Vigne
Giorgio Treglia

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2023.1362018

1,850 views

Review

Published on 10 Jan 2024

The application of radionuclide therapy for breast cancer

Anna Musket
Sandra Davern
Brianna M. Elam
Philip R. Musich
Jonathan P. Moorman
Yong Jiang

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2023.1323514

8,596 views
4 citations

Original Research

Published on 10 Jan 2024

Automatic deep learning method for third lumbar selection and body composition evaluation on CT scans of cancer patients

Lidia Delrieu
Damien Blanc
Amine Bouhamama
Fabien Reyal
Frank Pilleul
Victor Racine
Anne Sophie Hamy
Hugo Crochet
Timothée Marchal
Pierre Etienne Heudel

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2023.1292676

5,616 views
12 citations

Original Research

Published on 08 Jan 2024

PARALLELPROJ—an open-source framework for fast calculation of projections in tomography

Georg Schramm
Kris Thielemans

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2023.1324562

4,352 views
33 citations

Editorial

Published on 21 Dec 2023

Editorial: Insights in PET and SPECT: 2023

Mario Petretta
Carmela Nappi
Alberto Cuocolo

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2023.1342672

2,042 views

Perspective

Published on 14 Dec 2023

Quantitative imaging for 177Lu-PSMA treatment response monitoring and dosimetry

Catherine Meyer
Laszlo Szidonya
Celeste Winters
Anna Mench
Nadine Mallak
Erik Mittra

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2023.1291253

8,808 views
11 citations

Original Research

Published on 12 Dec 2023

Utilizing MRI, [18F]FDG-PET and [89Zr]Zr-DFO-28H1 FAP-PET tracer to assess inflammation and fibrogenesis in a reproducible lung injury rat model: a multimodal imaging study

Milou Boswinkel
René Raavé
Andor Veltien
Tom WJ Scheenen
Nina Fransén Petterson
René in ‘t Zandt
Lars E. Olsson
Karin von Wachenfeldt
Sandra Heskamp
Irma Mahmutovic Persson

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2023.1306251

3,615 views
8 citations

Editorial

Published on 11 Dec 2023

Editorial: Quantitative [18F]NaF PET in metastatic and metabolic bone diseases

Tanuj Puri
Amelia E. Moore
Abhishek Mahajan
Alan McWilliam
Marie H. Vrist
Glen M. Blake

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2023.1343913

2,481 views

Original Research

Published on 06 Dec 2023

A fast Monte Carlo cell-by-cell simulation for radiobiological effects in targeted radionuclide therapy using pre-calculated single-particle track standard DNA damage data

A. Lim
M. Andriotty
T. Yusufaly
G. Agasthya
B. Lee
C. Wang

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2023.1284558

3,036 views
7 citations

Editorial

Published on 27 Nov 2023

Editorial: Prof. Frank Rösch's legacy in the radiopharmaceutical chemistry field

Christian B. M. Poulie
Markus Piel
Bernd Neumaier
Tobias Ross
Matthias Herth

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2023.1336481

1,763 views

Case Report

Published on 27 Nov 2023

Case Report: Post-traumatic splenosis and potential pitfall for PSMA-PET

Marina Nearchou
Elizabeth Georgiou
Alexis Vrachimis
Konstantinos Ferentinos
Iosif Strouthos

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2023.1319952

2,303 views

Original Research

Published on 24 Nov 2023

Effects of dynamic [18F]NaF PET scan duration on kinetic uptake parameters in the knee

Lauren E. Watkins
Bryan Haddock
Ananya Goyal
Feliks Kogan

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2023.1194961

2,523 views
1 citation

Editorial

Published on 10 Nov 2023

Editorial: Rising stars in PET and SPECT: 2022

David Izquierdo-Garcia
Seung Kwan Kang

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2023.1326549

1,767 views

Case Report

Published on 26 Oct 2023

First use of 18F-FDG PET in TEMPI syndrome: can it be used for treatment assessment? A case report

Henri Pasquesoone
Aurélien Callaud
Thibaut Carsuzaa
Thomas Chalopin
Maria-Joao Santiago-Ribeiro

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2023.1273967

2,354 views

Review

Published on 25 Oct 2023

Emerging theragnostic radionuclide applications for hepatocellular carcinoma

N. E. Nyakale
C. Aldous
A. A. Gutta
X. Khuzwayo
L. Harry
M. M. Sathekge

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2023.1210982

4,233 views
5 citations

Hypothesis and Theory

Published on 13 Oct 2023

Radiopharmaceutical administration practices—Are they best practice?

Stephen Harris
James R. Crowley
Nancy Warden

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2023.1244660

5,748 views
5 citations

Mini Review

Published on 09 Oct 2023

Mini review of first-in-human integrin αvβ6 PET tracers

Richard H. Kimura
Andrei Iagaru
H. Henry Guo

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2023.1271208

6,833 views
13 citations

Brief Research Report

Published on 04 Oct 2023

[18F]NaF PET/CT imaging of response to single fraction SABR to bone metastases from breast cancer

Nicholas Hardcastle
Yang Liu
Shankar Siva
Steven David

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2023.1197397

2,638 views
2 citations

Review

Published on 21 Sep 2023

Evaluation of deep space exploration risks and mitigations against radiation and microgravity

William Dobney
Louise Mols
Dhruti Mistry
Kevin Tabury
Bjorn Baselet
Sarah Baatout

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2023.1225034

17,299 views
26 citations

Original Research

Published on 20 Sep 2023

Radiolabeled iron oxide nanoparticles functionalized with PSMA/BN ligands for dual-targeting of prostate cancer

Danae Efremia Bajwa
Evangelia-Alexandra Salvanou
Maria Theodosiou
Theodora S. Koutsikou
Eleni K. Efthimiadou
Penelope Bouziotis
Christos Liolios

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2023.1184309

3,512 views
3 citations

Original Research

Published on 14 Sep 2023

Multicentric 68Ga-PSMA PET radiomics for treatment response assessment of 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer

Robin Gutsche
Gizem Gülmüs
Felix M. Mottaghy
Florian Gärtner
Markus Essler
Dirk von Mallek
Hojjat Ahmadzadehfar
Philipp Lohmann
Alexander Heinzel

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2023.1234853

4,842 views
9 citations

Original Research

Published on 12 Sep 2023

Post-acquisition standardization of positron emission tomography images

Aliasghar Mortazi
Jayaram K. Udupa
Dewey Odhner
Yubing Tong
Drew A. Torigian

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2023.1210931

2,092 views
3 citations

Perspective

Published on 05 Sep 2023

To tell or not to tell … the patient about potential harm

Timothy L. Bartholow

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2023.1258960

2,307 views

56 Publications

volumes

Comparative effectiveness of standard vs. AI-assisted PET/CT reading workflow for pre-treatment lymphoma staging: a multi-institutional reader study evaluation

Editorial: Molecular imaging of cardiovascular diseases: current and emerging approaches in nuclear medicine

The application of radionuclide therapy for breast cancer

Automatic deep learning method for third lumbar selection and body composition evaluation on CT scans of cancer patients

PARALLELPROJ—an open-source framework for fast calculation of projections in tomography

Editorial: Insights in PET and SPECT: 2023

Quantitative imaging for 177Lu-PSMA treatment response monitoring and dosimetry

Utilizing MRI, [18F]FDG-PET and [89Zr]Zr-DFO-28H1 FAP-PET tracer to assess inflammation and fibrogenesis in a reproducible lung injury rat model: a multimodal imaging study

Editorial: Quantitative [18F]NaF PET in metastatic and metabolic bone diseases

A fast Monte Carlo cell-by-cell simulation for radiobiological effects in targeted radionuclide therapy using pre-calculated single-particle track standard DNA damage data

Editorial: Prof. Frank Rösch's legacy in the radiopharmaceutical chemistry field

Case Report: Post-traumatic splenosis and potential pitfall for PSMA-PET

Effects of dynamic [18F]NaF PET scan duration on kinetic uptake parameters in the knee

Editorial: Rising stars in PET and SPECT: 2022

First use of 18F-FDG PET in TEMPI syndrome: can it be used for treatment assessment? A case report

Emerging theragnostic radionuclide applications for hepatocellular carcinoma

Radiopharmaceutical administration practices—Are they best practice?

Mini review of first-in-human integrin αvβ6 PET tracers

[18F]NaF PET/CT imaging of response to single fraction SABR to bone metastases from breast cancer

Evaluation of deep space exploration risks and mitigations against radiation and microgravity

Radiolabeled iron oxide nanoparticles functionalized with PSMA/BN ligands for dual-targeting of prostate cancer

Multicentric 68Ga-PSMA PET radiomics for treatment response assessment of 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer

Post-acquisition standardization of positron emission tomography images

To tell or not to tell … the patient about potential harm